The ubiquitin-proteasome system (UPS) is a key pathway in many cancer cells, responsible for degrading tumor suppressor proteins and promoting oncogene expression, making abnormalities in ubiquitination a potential driver of HCC cells’ resistance to conventional treatments (Liao et al., 2020). The gene discussed is TCHP; the disease is cancer.